Pfizer Inc signs multi-year deal to manufacture Gilead’s coronavirus antiviral remdesivir
Pfizer Inc signs multi-year deal to manufacture Gilead’s coronavirus antiviral remdesivir to boost production of the drug Pfizer Inc has signed a multi-year deal with Gilead Sciences Inc to manufacture and supply the antiviral remdesivir The drug is the only one approved in the US to treat coronavirus patients by emergency use after it was … Read more